MOESM1 of Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes

Anderson, Monique; Pleet, Michelle; Enose-Akahata, Yoshimi; Erickson, James; Monaco, Maria; Akpamagbo, Yao; Velluci, Ashley; Tanaka, Yuetsu; Azodi, Shila; Lepene, Ben; Jones, Jennifer; Kashanchi, Fatah; Jacobson, Steven

doi:10.6084/m9.figshare.7011797.v1

sorry, we can't preview this file

40169_2018_204_MOESM1_ESM.pptx (2.2 MB)

MOESM1 of Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes

presentation

posted on 2018-08-27, 05:00 authored by Monique Anderson, Michelle Pleet, Yoshimi Enose-Akahata, James Erickson, Maria Monaco, Yao Akpamagbo, Ashley Velluci, Yuetsu Tanaka, Shila Azodi, Ben Lepene, Jennifer Jones, Fatah Kashanchi, Steven Jacobson

Additional file 1: Figure S1. Characterization of Nanotrapped (NT80 + 82) exosomes by Nanosight. Tissue culture supernatants from HTLV-1 infected cells prior to nanotrapping (Pre-NT) and after nanotrapping (+NT) were analyzed for size and concentration by Nanosight. Nanotrapped exosomes (+NT) were resuspended in 300 μL for imaging. NT80 + 82 particles alone (NT Alone) were also analyzed. Pre-nanotrapped (Pre-NT) and post-nanotrapped (post NT) vesicle distributions were likewise analyzed according to size and shown in the right panel inset.